To date, there are only two studies mentioning de novo FXS cases with gain and loss CNV of the ASFMR1/FMR4 gene (Nagamani et al., 2012; Vengoechea et al., 2012). This evidence concerns the gene FMR1-AS1 and fragile X syndrome.